ARTICLE | Company News
Santaris, Bristol-Myers deal
April 22, 2013 7:00 AM UTC
Santaris and Bristol-Myers partnered to discover and develop RNA-targeted therapies for undisclosed indications using the biotech's Locked Nucleic Acid (LNA) technology. Santaris will receive $10 mill...